Last reviewed · How we verify

NCT06275165

The Effects of Acupressure on Improving Postoperative Gastrointestinal Symptom Distress in Esophageal Cancer Patients

Completed NA Last updated 7 August 2025
What this trial tests

NA trial testing acupressure in Esophageal Cancer in 48 participants. Completed in 18 July 2025.

Timeline
27 March 2024
Primary endpoint
18 July 2025
18 July 2025

Quick facts

Lead sponsorCHEN, CHIA-CHEN
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment48
Start date27 March 2024
Primary completion18 July 2025
Estimated completion18 July 2025
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

CHEN, CHIA-CHEN

Who can join

Adults 18 to 85, any sex, with Esophageal Cancer or Gastrointestinal Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a quasi-experimental design clinical trial with the primary objective of comparing the health status of patients with esophageal cancer. Participants were divided into an experimental group and a control group. Patients in the experimental group received routine care and acupressure for 5 consecutive days starting from the day after entering the ward after esophageal cancer surgery, in the control group, participants received routine care, and Participants were assessed on the Gastrointestinal Symptom Distress Scale at the end of the intervention. The aim of this study was to verify the effectiveness of acupressure in improving of gastrointestinal symptoms distress after esophageal cancer surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of acupressure

Trials testing the same drug.

Other recruiting trials for Esophageal Cancer

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06275165.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing